Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wiese

Showing results (141-150 of 272) with videos related to

Pageof 28
Sort By:
Obesity (Silver Spring, Md.)|August 30, 2024
Maternal obesogenic diet during pregnancy and its impact on fetal hepatic function in baboonsAshley S Meakin, Peter W Nathanielsz, Cun Li, et al.
The Journal of Allergy and Clinical Immunology. Global|June 8, 2026
Stability of proton pump inhibitors for use in hypersensitivity evaluationTroy Wanandy, Simon A Handley, Rahul P Patel, et al.
BMJ Open|June 21, 2018
Validation of discharge diagnosis codes to identify serious infections among middle age and older adultsAndrew D Wiese, Marie R Griffin, C Michael Stein, et al.
Journal of the American Geriatrics Society|December 20, 2016
Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic ReviewBarbara C Wimmer, Amanda J Cross, Natali Jokanovic, et al.
American Journal of Obstetrics & Gynecology MFM|December 19, 2020
Variation in discharge opioid prescribing after vaginal birthsJea Young Min, Sarah S Osmundson, Marie R Griffin, et al.
Plos One|May 13, 2020
Methamphetamine administration increases hepatic CYP1A2 but not CYP3A activity in female guinea pigsJia Yin Soo, Michael D Wiese, Rebecca M Dyson, et al.
Pharmacology Research & Perspectives|July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicinesAshley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
British Journal of Cancer|September 27, 2017
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markersAshley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, et al.
Therapeutic Advances in Musculoskeletal Disease|April 29, 2021
Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a <i>post hoc</i> multicohort analysisAhmad Y Abuhelwa, David J R Foster, Arkady Manning-Bennett, et al.
Patient Education and Counseling|December 4, 2025
Patients' attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritisLauren Fraser, Michael D Wiese, Nagham Ailabouni, et al.
Pageof 28

Showing results (141-150 of 272) with videos related to

Sort By:
Pageof 28
Obesity (Silver Spring, Md.)|August 30, 2024
Maternal obesogenic diet during pregnancy and its impact on fetal hepatic function in baboonsAshley S Meakin, Peter W Nathanielsz, Cun Li, et al.
The Journal of Allergy and Clinical Immunology. Global|June 8, 2026
Stability of proton pump inhibitors for use in hypersensitivity evaluationTroy Wanandy, Simon A Handley, Rahul P Patel, et al.
BMJ Open|June 21, 2018
Validation of discharge diagnosis codes to identify serious infections among middle age and older adultsAndrew D Wiese, Marie R Griffin, C Michael Stein, et al.
Journal of the American Geriatrics Society|December 20, 2016
Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic ReviewBarbara C Wimmer, Amanda J Cross, Natali Jokanovic, et al.
American Journal of Obstetrics & Gynecology MFM|December 19, 2020
Variation in discharge opioid prescribing after vaginal birthsJea Young Min, Sarah S Osmundson, Marie R Griffin, et al.
Plos One|May 13, 2020
Methamphetamine administration increases hepatic CYP1A2 but not CYP3A activity in female guinea pigsJia Yin Soo, Michael D Wiese, Rebecca M Dyson, et al.
Pharmacology Research & Perspectives|July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicinesAshley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
British Journal of Cancer|September 27, 2017
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markersAshley M Hopkins, Andrew Rowland, Ganessan Kichenadasse, et al.
Therapeutic Advances in Musculoskeletal Disease|April 29, 2021
Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a <i>post hoc</i> multicohort analysisAhmad Y Abuhelwa, David J R Foster, Arkady Manning-Bennett, et al.
Patient Education and Counseling|December 4, 2025
Patients' attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritisLauren Fraser, Michael D Wiese, Nagham Ailabouni, et al.
Pageof 28